What happens when the regulatory systems we depend on to protect us break down?

In February, President Trump signed an executive order invoking the Defense Production Act — a wartime authority — to guarantee the domestic supply of glyphosate, the active ingredient in Roundup, the world’s most widely used weedkiller. The order extends legal immunity to its producers. It came one day after Bayer proposed a $7.25 billion settlement to resolve tens of thousands of cancer lawsuits without admitting wrongdoing.

The World Health Organization classifies glyphosate as a probable carcinogen.

Separately, the Supreme Court hears oral arguments April 27 in a case that could shut down state-level Roundup lawsuits nationwide. The EPA faces an October deadline to rule on glyphosate safety — with most of its research staff gone.

Last month on The Metro, Harvard historian Naomi Oreskes explained how the landmark safety study behind Roundup was ghostwritten by Monsanto, cited by regulators worldwide for 25 years, and finally retracted after she and researcher Alexander Kaurov documented its influence. Since then, she has identified more scientific research ghostwritten by Monsanto.

To discuss, Oreskes, author of “Merchants of Doubt,” returned to The Metro to join Robyn Vincent.

Hear the full conversation using the media player above.

Listen to The Metro weekdays from 10 a.m. to noon ET on 101.9 FM and streaming on demand.

Subscribe to The Metro on Apple Podcasts, Spotify, NPR.org or wherever you get your podcasts.

More stories from The Metro

It’s a medical mystery with destructive elements. Our cells divide and grow with unstoppable force. They seize surrounding tissue. They invade from within. 

That’s how cancer works. And cases of younger people getting cancer — folks under the age of 50 — have been growing. Someone born in 1990 is now four times more likely to get rectal cancer, and two times more likely to get colon cancer than someone born in 1950. 

Why? And, what is it like to be a doctor in metro Detroit fielding these cases?

Dr. Thomas Kelly is a gastroenterologist at the Karmanos Cancer Institute. He spoke with The Metro‘s Robyn Vincent about different dietary and environmental factors that may be contributing to rising cancer rates.

Listen to The Metro weekdays from 10 a.m. to noon ET on 101.9 FM and streaming on demand.

Subscribe to The Metro on Apple Podcasts, Spotify, NPR.org or wherever you get your podcasts.

More stories from The Metro

When a government agency decides whether a chemical in your food is safe, where does the science come from? Most of us assume it’s independent. In the case of Roundup — the world’s most widely used weedkiller — the manufacturer wrote the research, and it went unchallenged for 25 years.

In 2000, a study published in the journal Regulatory Toxicology and Pharmacology concluded Roundup posed no health risk to humans. But internal Monsanto emails released in 2017 litigation revealed company employees had ghostwritten the paper. Despite that, it remained in the scientific record, cited without caveat in hundreds of academic papers and dozens of government documents worldwide.

Harvard historian of science Naomi Oreskes and researcher Alexander Kaurov changed that. Their 2025 analysis found the ghostwritten paper ranked in the top 0.1% of all cited glyphosate literature. They requested the journal retract it. In November 2025, it did, citing “serious ethical concerns.” Oreskes and Kaurov also wrote about their findings in Undark.

The retraction comes as Bayer, which acquired Monsanto in 2018, faces roughly 65,000 Roundup cancer lawsuits. On February 17, the company proposed a $7.25 billion class settlement. The U.S. Supreme Court has agreed to hear a related case this term. Bayer maintains glyphosate is safe.

Oreskes, author of “Merchants of Doubt,” joined Robyn Vincent on The Metro to discuss how one ghostwritten paper shaped pesticide policy for a generation, and what it means now that it’s been thrown out.

Hear the full conversation using the media player above.

Listen to The Metro weekdays from 10 a.m. to noon ET on 101.9 FM and streaming on demand.

Subscribe to The Metro on Apple Podcasts, Spotify, NPR.org or wherever you get your podcasts.

More stories from The Metro